Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab

por Gingele, Stefan, Skripuletz, Thomas, Jacobs, Roland
Publicado 2019

The choline pathway as a strategy to promote central nervous system (CNS) remyelination

por Skripuletz, Thomas, Linker, Ralf A., Stangel, Martin
Publicado 2015

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

por Gudi, Viktoria, Gingele, Stefan, Skripuletz, Thomas, Stangel, Martin
Publicado 2014

Neuroimmunologie von COVID‑19

por Skripuletz, Thomas, Möhn, Nora, Franke, Christiana, Prüß, Harald
Publicado 2021

CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial

por Gudi, Viktoria, Grieb, Paweł, Linker, Ralf A., Skripuletz, Thomas
Publicado 2023

Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis

por Salinas Tejedor, Laura, Skripuletz, Thomas, Stangel, Martin, Gudi, Viktoria
Publicado 2016

Leistungsfähigkeit der McDonald-Kriterien von 2017

por Konen, Franz Felix, Schwenkenbecher, Philipp, Wattjes, Mike P., Skripuletz, Thomas
Publicado 2022

Multiple Levels of Control Processes for Wisconsin Card Sorts: An Observational Study

por Kopp, Bruno, Steinke, Alexander, Bertram, Malte, Skripuletz, Thomas, Lange, Florian
Publicado 2019

Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination

por Gudi, Viktoria, Schäfer, Nora, Gingele, Stefan, Stangel, Martin, Skripuletz, Thomas
Publicado 2021

Varicella Zoster Virus Meningitis in a Young Immunocompetent Adult without Rash: A Misleading Clinical Presentation

por Pasedag, Thomas, Weissenborn, Karin, Wurster, Ulrich, Ganzenmueller, Tina, Stangel, Martin, Skripuletz, Thomas
Publicado 2014

Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis

por Yildiz, Özlem, Pul, Refik, Raab, Peter, Hartmann, Christian, Skripuletz, Thomas, Stangel, Martin
Publicado 2015

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook

por Möhn, Nora, Beutel, Gernot, Gutzmer, Ralf, Ivanyi, Philipp, Satzger, Imke, Skripuletz, Thomas
Publicado 2019

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab

por Möhn, Nora, Skripuletz, Thomas, Sühs, Kurt-Wolfram, Menck, Sylvia, Voß, Elke, Stangel, Martin
Publicado 2019

Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C

por Konen, Franz Felix, Maier, Hannah Benedictine, Neyazi, Alexandra, Bleich, Stefan, Neumann, Konstantin, Skripuletz, Thomas
Publicado 2023

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

por Möhn, Nora, Luo, Yi, Skripuletz, Thomas, Schwenkenbecher, Philipp, Zerr, Inga, Lange, Peter, Stangel, Martin
Publicado 2019

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS

por Möhn, Nora, Pul, Refik, Kleinschnitz, Christoph, Prüss, Harald, Witte, Torsten, Stangel, Martin, Skripuletz, Thomas
Publicado 2020

Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse

por Moharregh-Khiabani, Darius, Blank, Alexander, Skripuletz, Thomas, Miller, Elvira, Kotsiari, Alexandra, Gudi, Viktoria, Stangel, Martin
Publicado 2010

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials

por Bayas, Antonios, Christ, Monika, Faissner, Simon, Klehmet, Juliane, Pul, Refik, Skripuletz, Thomas, Meuth, Sven G.
Publicado 2023

Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA receptor encephalitis

por SÜHS, KURT-WOLFRAM, WEGNER, FLORIAN, SKRIPULETZ, THOMAS, TREBST, CORINNA, TAYEB, SAID BEN, RAAB, PETER, STANGEL, MARTIN
Publicado 2015

Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies

por Sühs, Kurt-Wolfram, Skripuletz, Thomas, Pul, Refik, Alvermann, Sascha, Schwenkenbecher, Philipp, Stangel, Martin, Müller-Vahl, Kirsten
Publicado 2015